IDEAYA Biosciences (IDYA) Other Non Operating Income (2018 - 2019)

IDEAYA Biosciences (IDYA) reported Other Non Operating Income of $2000.0 for Q4 2019, down 66.67% sequentially from $6000.0 in Q2 2019.

IDEAYA Biosciences (IDYA) Other Non Operating Income (2018 - 2019) Analysis & Trends

IDEAYA Biosciences (IDYA) has 2 years of Other Non Operating Income data on file, last reported at $2000.0 in Q4 2019.

For the quarter ending Q4 2019, Other Non Operating Income changed N/A year-over-year to $2000.0; the trailing twelve-month figure through Dec 2019 stood at $8000.0 (changed N/A YoY), and the FY2019 full-year result was $8000.0, down 89.61% from the prior year.
Other Non Operating Income fell to $2000.0 in Q4 2019, from $6000.0 in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $8000.0 in Q2 2018 to a low of $1000.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	IDEAYA Biosciences	3.21 Bn	2.54 Bn	-

Download Data